Apex Biotechnology Corp. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 529.084 million compared to TWD 541.760 million a year ago. Operating income was TWD 32.042 million compared to TWD 30.406 million a year ago. Net income was TWD 26.760 million compared to TWD 27.949 million a year ago. Basic earnings per share was TWD 0.27 compared to TWD 0.28 a year ago. Diluted earnings per share was TWD 0.25 compared to TWD 0.26 a year ago. For the half year, sales was TWD 1,041.014 million compared to TWD 1,066.694 million a year ago. Operating income was TWD 47.129 million compared to TWD 65.066 million a year ago. Net income was TWD 38.728 million compared to TWD 49.687 million a year ago. Basic earnings per share was TWD 0.39 compared to TWD 0.5 a year ago. Diluted earnings per share was TWD 0.36 compared to TWD 0.46 a year ago.